Hirschsprung's Disease

Disclaimer: > [!WARNING] Medical Disclaimer: This content is for educational and informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional for diagnosis and treatment. Medical guidelines and best practices change rapidly; users should verify information with current local protocols.

1. Overview

Hirschsprung's Disease (HD) is a congenital neurocristopathy characterised by the absence of enteric ganglion cells (aganglionosis) in the distal bowel. This creates a functional intestinal obstruction because the affected segment cannot relax, remaining in a state of tonic contraction. [1,2]

Key Pathophysiological Concepts

1. Aganglionosis: Complete absence of ganglion cells in both the Myenteric (Auerbach's) and Submucosal (Meissner's) plexuses in the affected bowel segment.
2. Functional Obstruction: The aganglionic segment remains tonically contracted and cannot propagate peristaltic waves.
3. Proximal Megacolon: The proximal, normally innervated bowel dilates secondary to chronic downstream obstruction.
4. Always Includes Anus: Due to craniocaudal migration of neural crest cells, the aganglionosis always involves the anus and extends proximally for a variable distance.

Clinical Significance

Hirschsprung's disease is the most common cause of neonatal bowel obstruction requiring surgery, and represents a true surgical emergency in the newborn period. Early recognition and appropriate surgical intervention are critical to prevent life-threatening complications, particularly Hirschsprung-associated enterocolitis (HAEC). [3]

---

2. Epidemiology

Incidence and Demographics

• Overall Incidence: Approximately 1 in 5,000 live births in European populations. [1,2]
• Geographic Variation: Higher incidence in Asian populations (up to 1 in 3,000).
• Sex Distribution:
  • "Male predominance overall (4:1 in short-segment disease)"
  • "More equal distribution in long-segment and total colonic aganglionosis (M:F ratio approaches 1:1)"
• Segment Distribution:
  • "Short-segment (rectosigmoid): 80% of cases"
  • "Long-segment (extends beyond sigmoid): 15% of cases"
  • "Total colonic aganglionosis (TCA): 5% of cases"
  • "Total intestinal aganglionosis: less than 1% (extremely rare, often fatal)"

Genetic and Syndromic Associations

Trisomy 21 (Down Syndrome): The most common chromosomal association. [4,5]

• Occurs in 10-15% of all Hirschsprung's patients
• Conversely, approximately 2-10% of children with Down syndrome have HD
• These patients tend to have longer segment disease
• Higher risk of post-operative complications and HAEC

RET Proto-Oncogene Mutations: [1,6]

• Found in approximately 50% of familial cases and 15-20% of sporadic cases
• RET is a receptor tyrosine kinase essential for enteric nervous system development
• Somatic and germline mutations have been identified
• Loss-of-function mutations prevent neural crest cell migration and differentiation
• Variable penetrance and expressivity explain phenotypic variation

Other Genetic Associations:

• EDNRB (Endothelin Receptor B) gene mutations
• EDN3 (Endothelin-3) gene mutations
• SOX10 mutations (associated with Waardenburg-Shah syndrome)
• Multiple Endocrine Neoplasia Type 2 (MEN 2A and 2B)
• Congenital Central Hypoventilation Syndrome (CCHS) - "Haddad syndrome"

Additional Syndromic Associations:

• Waardenburg syndrome (deafness, heterochromia)
• Bardet-Biedl syndrome
• Cartilage-hair hypoplasia
• Smith-Lemli-Opitz syndrome
• Mowat-Wilson syndrome (microcephaly, developmental delay, distinctive facial features)

Familial Risk

• Sibling recurrence risk:
  • "Short-segment: ~3-4%"
  • "Long-segment: ~15-20%"
• Offspring of affected parent: Variable (2-50% depending on sex and segment length)
• Genetic counselling is recommended for familial cases

---

3. Molecular Pathophysiology

Embryological Development of the Enteric Nervous System

The enteric nervous system (ENS) is the largest and most complex division of the peripheral nervous system, containing approximately 200-600 million neurons in humans - as many as the spinal cord. [7]

Normal Development (Weeks 4-12 of Gestation):

1. Week 4: Vagal neural crest cells (from rhombomeres 6-8) begin migration
2. Week 5-7: Craniocaudal migration along the entire length of the gut
3. Week 7: Neural crest cells reach the caecum
4. Week 12: Colonization of hindgut and rectum complete
5. Weeks 12-16: Ganglion cell differentiation and plexus formation

Sacral Contribution:

• Sacral neural crest cells (somites S1-S3) also contribute
• They colonize the hindgut in a caudocranial direction
• Less critical than vagal neural crest cells

Pathophysiology of Hirschsprung's Disease

Failed Migration Hypothesis: [1,2,7]

1. Arrest of Migration: Neural crest cells fail to complete their craniocaudal migration
2. Hostile Microenvironment: The distal gut may be inhospitable to neural crest cell colonization
3. Premature Differentiation: Cells differentiate before reaching their destination
4. Increased Apoptosis: Excessive programmed cell death of migrating neuroblasts

Molecular Mechanisms:

RET Signaling Pathway: [6]

• RET is activated by Glial Cell Line-Derived Neurotrophic Factor (GDNF)
• GDNF-RET signaling is essential for:
  • Neural crest cell survival
  • Migration and proliferation
  • Differentiation into enteric neurons
• Loss-of-function mutations → impaired migration → aganglionosis

Endothelin Pathway:

• EDN3-EDNRB signaling regulates neural crest cell migration
• Mutations cause arrest at the proximal hindgut
• Particularly associated with longer segment disease

Consequences of Aganglionosis:

1. Loss of Peristalsis:

   • Absence of coordinated smooth muscle contraction
   • No propagation of peristaltic waves through affected segment

2. Tonic Contraction:

   • Unopposed sympathetic (extrinsic) innervation
   • Loss of inhibitory nitric oxide (NO) neurons
   • Segment remains in sustained contraction

3. Functional Obstruction:

   • Stool and gas cannot pass through the narrow, contracted segment
   • Proximal bowel dilates progressively

4. Histological Changes:

   • Hypertrophied nerve trunks: Extrinsic cholinergic fibres are increased and abnormally large
   • Increased Acetylcholinesterase: Abnormal AChE staining in lamina propria and muscularis mucosae
   • Absence of ganglion cells: Must examine adequate submucosa (Meissner's plexus)

---

4. Classification

By Anatomical Extent

Short-Segment Disease (80%):

• Involves rectum and sigmoid colon only
• Transition zone typically at rectosigmoid junction
• Male:Female ratio 4:1
• Generally better prognosis

Long-Segment Disease (15%):

• Extends beyond sigmoid colon
• May reach splenic flexure, transverse colon, or hepatic flexure
• More equal sex distribution
• Increased risk of complications

Total Colonic Aganglionosis (TCA) (5%): [8,9]

• Entire colon lacks ganglion cells
• Transition zone in terminal ileum
• May extend into small bowel (total intestinal aganglionosis)
• Significant management challenges
• Higher morbidity and mortality

Ultra-Short Segment Disease (Variant):

• Confined to internal anal sphincter
• Controversial diagnosis
• May present later in childhood with chronic constipation
• Diagnosis via anorectal manometry (absent RAIR) and anal sphincter biopsy

By Presentation

Neonatal (75-80%):

• Presents in first weeks of life
• Delayed meconium passage, bilious vomiting, abdominal distension

Infant/Childhood (15-20%):

• Presents with chronic severe constipation
• Failure to thrive
• May be delayed diagnosis

Adult (less than 5%):

• Extremely rare
• Ultra-short segment or mild short-segment disease
• Lifelong constipation often attributed to other causes

---

5. Clinical Presentation

Neonatal Presentation (Most Common)

Cardinal Sign - Delayed Meconium Passage: [2,3]

• >90% of term infants with HD fail to pass meconium within 48 hours
• Normal infants: 95% pass meconium within 24 hours, 99% within 48 hours
• Meconium plug syndrome may be the presenting feature (but HD must be excluded)

Classic Triad:

1. Delayed meconium passage (>48 hours)
2. Abdominal distension (progressive, tympanic)
3. Bilious vomiting (green, indicates obstruction distal to Ampulla of Vater)

Additional Signs:

• Poor feeding: Reluctance to feed due to abdominal discomfort
• "Blast Sign" or "Squirt Sign": Explosive expulsion of gas and stool upon withdrawal of examining finger during rectal examination. This temporarily relieves the obstruction and is highly suggestive of HD.
• Respiratory distress: Severe abdominal distension can compromise diaphragmatic excursion

Hirschsprung-Associated Enterocolitis (HAEC): [10,11]

• Can be the presenting feature in up to 30% of neonatal cases
• Life-threatening complication - mortality up to 30% if untreated
• Presents with:
  • Fever and systemic toxicity
  • Explosive, foul-smelling, bloody diarrhoea
  • Severe abdominal distension
  • "Signs of septic shock: tachycardia, hypotension, poor perfusion"
• Pathophysiology: Stasis → bacterial overgrowth → mucosal ischaemia → bacterial translocation → sepsis
• Organisms: Clostridium difficile, Staphylococcus aureus, Enterococcus, anaerobes

Infant and Childhood Presentation

Chronic Constipation: [2,3]

• Severe, refractory to conventional laxative therapy
• Onset from early infancy (unlike functional constipation which typically starts after weaning)
• "Ribbon-like" or "pellet" stools - thin calibre due to narrow distal segment

Failure to Thrive:

• Poor weight gain despite adequate caloric intake
• Chronic abdominal distension leads to early satiety
• Malabsorption in severe cases

Distinguishing Features from Functional Constipation:

Other Presentations:

• Chronic diarrhoea: Paradoxical - overflow around obstructing segment
• Recurrent abdominal pain and distension
• Recurrent episodes suggestive of HAEC

---

6. Clinical Examination

General Inspection

Dysmorphic Features:

• Examine for Down syndrome stigmata (upslanting palpebral fissures, epicanthic folds, single palmar crease, hypotonia)
• Features of other syndromes (Waardenburg, Mowat-Wilson)

Nutritional Status:

• Assess growth parameters (weight, length, head circumference)
• Plot on centile charts - look for failure to thrive or crossing centiles

Hydration Status:

• Mucous membranes, capillary refill time, skin turgor
• Sunken fontanelle in infants
• Signs of shock in HAEC

Abdominal Examination

Inspection:

• Marked distension: May have visibly dilated bowel loops
• Visible peristalsis: Waves propagating across abdomen
• Shiny skin: Suggests chronic/severe distension
• Surgical scars: Previous operations (stomas, biopsies)

Palpation:

• Faecal masses: Palpable in flanks (dilated proximal colon)
• Tenderness: Suggests HAEC or perforation
• Peritonism: Guarding, rigidity - surgical emergency

Percussion:

• Tympanic: Gas-filled dilated loops predominate

Auscultation:

• Tinkling bowel sounds in obstruction
• Absent sounds if ileus or perforation has occurred

Perineal and Anorectal Examination

Inspection:

• Anal position: Normal (exclude anorectal malformation)
• Patency: Confirm anus is present and patent
• Fistulae: Rare, but check in complex cases

Digital Rectal Examination: [2]

• Anal sphincter tone: Characteristically very tight (increased resting tone)
• Rectal ampulla: Empty and narrow (collapsed)
  • "In functional constipation: rectum is ballooned and loaded with stool"
• "Blast Sign": On withdrawal of examining finger, explosive passage of gas and stool is diagnostic
• Do NOT perform vigorous PR examination in a sick neonate with suspected HAEC - risk of perforation

Caveats:

• In neonates with recent rectal stimulation/washouts, the "blast sign" may be absent
• In total colonic aganglionosis, the transition zone may not be palpable

---

7. Differential Diagnosis

Neonatal Intestinal Obstruction

Meconium Ileus: [12]

• Associated with Cystic Fibrosis (>90% of cases)
• Inspissated meconium obstructs terminal ileum
• AXR: "ground glass" appearance, microcolon on contrast enema
• Gastrografin enema may be therapeutic
• Sweat test and genetic testing for CF

Intestinal Atresia:

• Jejunoileal or colonic atresia
• Complete luminal obstruction
• AXR: dilated loops with air-fluid levels, no distal gas
• Contrast enema: microcolon
• Requires surgical resection and anastomosis

Malrotation with Volvulus:

• Surgical emergency - midgut ischaemia
• Bilious vomiting in first days/weeks of life
• Upper GI contrast study: abnormal duodenojejunal flexure, "corkscrew" sign
• Requires urgent Ladd's procedure

Meconium Plug Syndrome:

• Functional obstruction from meconium plug
• Often resolves with contrast enema (therapeutic)
• Must exclude HD - perform rectal biopsy if red flags present

Anorectal Malformation:

• Imperforate anus, fistula (rectovesical, rectourethral, rectovaginal)
• Obvious on perineal examination
• Surgical repair required

Necrotising Enterocolitis (NEC):

• Premature infants
• Abdominal distension, bloody stools, pneumatosis intestinalis on X-ray
• Medical management; surgery if perforation/necrosis

Chronic Constipation in Older Infants/Children

Functional Constipation:

• Most common cause of childhood constipation (>90%)
• Onset typically after weaning/toilet training
• Loaded rectum on examination
• Responds to laxatives and behavioural measures

Hypothyroidism:

• Constipation, lethargy, poor growth, prolonged jaundice
• Low T4, elevated TSH

Hypercalcaemia:

• Constipation, polyuria, abdominal pain
• Measure serum calcium and PTH

Coeliac Disease:

• Can present with constipation (though diarrhoea more common)
• Serology: anti-tTG antibodies, EMA
• Small bowel biopsy

Spinal Dysraphism:

• Spina bifida occulta, tethered cord
• Neurogenic bowel/bladder
• Examine spine for midline defects, hairy patch, sacral dimple
• MRI spine

---

8. Investigations

Initial Laboratory Tests

Routine Bloods (if unwell or pre-operative):

• Full Blood Count: WCC elevated in HAEC/sepsis; anaemia if chronic
• Urea and Electrolytes: Dehydration, electrolyte imbalance (hypokalaemia, metabolic alkalosis from vomiting)
• C-Reactive Protein: Elevated in HAEC
• Blood Cultures: If febrile or septic
• Venous Blood Gas: Assess acid-base status, lactate (marker of bowel ischaemia/sepsis)

Genetic Testing (if indicated):

• Karyotype: Suspected Down syndrome
• RET gene sequencing: Familial cases, syndromic features, family planning
• Screening for associated conditions (e.g., PHOX2B in suspected CCHS)

Radiology

Abdominal Radiograph (AXR): [2,3]

• Non-specific but supports diagnosis
• Findings:
  • Dilated loops of bowel
  • Absence of gas in rectum (empty rectum)
  • Air-fluid levels (distal obstruction)
  • "Soap bubble" sign (mixed gas and meconium)
• HAEC: Severe distension, pneumatosis, portal venous gas (late sign), perforation (pneumoperitoneum)

Contrast Enema (Water-Soluble Contrast): [2,13]

• Diagnostic yield: 70-80% sensitivity in neonates
• Technique:
  • No prior rectal examination or washouts (to avoid false negatives)
  • Gently introduce contrast into rectum
  • AP and lateral views
• Findings:
  • "Transition Zone: Funnel-shaped area where narrow distal (aganglionic) segment meets dilated proximal (ganglionic) bowel"
  • "Rectosigmoid Ratio: Normal = rectum wider than sigmoid (ratio >1). In HD, ratio less than 1 (reversed)"
  • "Delayed Evacuation: Contrast retention >24 hours after enema is abnormal"
• Limitations:
  • Transition zone may not be evident in neonates less than 1 week (bowel not yet dilated)
  • "Total colonic aganglionosis: no transition zone, entire colon appears narrow"
  • False negatives in ultra-short segment disease

Abdominal Ultrasound:

• Not diagnostic, but can assess for bowel wall thickening in HAEC
• Rule out other causes of obstruction

Anorectal Manometry

Principle: [2,14]

• Measures recto-anal inhibitory reflex (RAIR)
• Normally, rectal distension → reflex relaxation of internal anal sphincter (mediated by enteric neurons)
• In HD: RAIR is absent (no ganglion cells to mediate reflex)

Technique:

• Small balloon catheter inserted into rectum
• Balloon inflated to distend rectum
• Pressure sensors measure anal sphincter response

Findings:

• Normal: Internal sphincter relaxation when rectum distended
• Hirschsprung's: No relaxation (absent RAIR)

Limitations:

• Requires patient cooperation (difficult in neonates/young infants)
• Operator-dependent
• False positives: ultra-short segment HD may have normal RAIR

Role:

• Useful screening tool in older infants/children with chronic constipation
• If RAIR absent → proceed to rectal biopsy
• If RAIR present → HD very unlikely

Rectal Suction Biopsy (Gold Standard)

Principle: [13,15]

• Obtain adequate submucosal tissue to assess for ganglion cells
• Can be performed at bedside (no general anaesthesia)

Technique:

1. Suction Biopsy Device: Rowe, Noblett, or similar
2. Site: 2-3 cm above dentate line (to avoid internal sphincter - normally aganglionic)
3. Multiple Samples: At least 2-3 biopsies to ensure adequate submucosa
4. Depth: Must include submucosa (Meissner's plexus)

Histological Examination: [15]

Normal:

• Ganglion cells present in submucosal plexus
• Ganglion cells are large, with vesicular nuclei and prominent nucleoli
• Typically seen in clusters

Hirschsprung's Disease:

1. Absence of ganglion cells in submucosa (must examine adequate submucosa)
2. Hypertrophied nerve trunks: Extrinsic nerve fibres are large and numerous
3. Positive Acetylcholinesterase (AChE) Staining:
   • Increased AChE activity in lamina propria, muscularis mucosae, and muscularis propria
   • Parasympathetic nerve fibres traverse upwards into mucosa (abnormal)
   • Highly sensitive and specific for HD

Pitfalls:

• Inadequate Sample: Mucosa only (no submucosa) → cannot diagnose
• Too Distal: Biopsy of internal sphincter (physiologically aganglionic)
• Immaturity: Premature infants may have immature ganglion cells (hypoganglionosis)
• Interobserver Variability: Require experienced paediatric pathologist

Sensitivity and Specificity: >95% when adequate tissue obtained and experienced pathologist

Full-Thickness Rectal Biopsy

Indications:

• Inadequate or equivocal suction biopsy
• Suspected rare variants (hypoganglionosis, neuronal intestinal dysplasia)

Technique:

• Requires general anaesthesia
• Posterior rectal wall, 2-3 cm above dentate line
• Transmural biopsy (includes myenteric plexus - Auerbach's)

Advantages:

• Larger tissue sample
• Includes myenteric plexus (more ganglion cells than submucosal plexus)
• Definitive diagnosis

Disadvantages:

• Requires GA
• Risk of bleeding, perforation (rare)
• Usually reserved for difficult cases

---

9. Management

Initial Stabilisation and Decompression

All Neonates with Suspected HD: [2,3]

1. Nil by Mouth (NBM): Stop all oral/enteral feeds
2. Nasogastric Tube: Large bore, on free drainage (decompress stomach)
3. Intravenous Fluids: Maintenance fluids + replace losses
   • Neonates: 150 mL/kg/day initially
   • Add potassium once urine output established
   • Correct electrolyte imbalances (metabolic alkalosis, hypokalaemia from vomiting)
4. Rectal Washouts/Irrigations: [16]
   • Indications: Relieve obstruction, decompress bowel, prevent HAEC
   • Technique:
     • Use large-bore catheter (14-16F)
     • Normal saline at body temperature
     • 10-20 mL/kg per washout, repeated until clear
     • Catheter tip must be above aganglionic segment (6-10 cm in neonate)
   • Frequency: 2-4 times daily until definitive surgery
   • Can be taught to parents for home management in delayed surgery

HAEC - Emergency Management: [10,11]

• ABC Resuscitation: 100% oxygen, IV fluid boluses (20 mL/kg), inotropes if shocked
• Broad-Spectrum IV Antibiotics:
  • Metronidazole (anaerobic cover, C. difficile)
  • Gentamicin or Ceftriaxone (Gram-negative cover)
  • Consider adding Vancomycin if Staph suspected
• Urgent Rectal Washouts: Decompress colon, remove stagnant stool
• NBM, NG Tube, IV Fluids
• Serial Abdominal Examinations: Watch for perforation
• May require Emergency Colostomy: If perforation, severe toxicity, or failed medical management

Definitive Surgical Management

Principles: [2,17,18]

• Remove aganglionic segment
• Bring ganglionic bowel down to anus ("pull-through")
• Preserve sphincter function and continence

Timing of Surgery:

• Traditionally: Two-stage approach
  • "Stage 1: Levelling colostomy (proximal to transition zone) in neonatal period"
  • "Stage 2: Definitive pull-through at 6-12 months"
• Modern Practice: Single-stage primary pull-through without colostomy is now standard in most centres (if infant is stable, no HAEC, and bowel not massively dilated) [18]

Colostomy Indications (Now Less Common):

• Severe HAEC/sepsis
• Massive colonic dilatation
• Delayed diagnosis with significant morbidity
• Malnutrition/failure to thrive
• Total colonic aganglionosis
• Surgeon preference/expertise

Pull-Through Procedures:

1. Swenson Procedure (1948)

Technique:

• Excision of entire aganglionic segment
• End-to-end anastomosis of ganglionic bowel to anus (1-2 cm above dentate line)
• Classically open transabdominal and perineal approach

Advantages:

• Complete removal of abnormal bowel
• Excellent long-term outcomes

Disadvantages:

• Extensive pelvic dissection → risk of pelvic nerve injury (bladder/sexual dysfunction)
• Technically demanding

2. Duhamel Procedure (1956)

Technique:

• Aganglionic rectum left in situ (closed as blind pouch)
• Ganglionic colon brought down retrorectally (behind the rectal stump)
• Side-to-side anastomosis creates common channel

Advantages:

• Less pelvic dissection → lower risk of nerve injury
• Technically easier

Disadvantages:

• Leaves aganglionic segment in place (potential for HAEC)
• Risk of faecal retention in rectal stump

3. Soave Procedure (Endorectal Pull-Through, 1964)

Technique:

• Mucosectomy: Strip mucosa of distal rectum
• Ganglionic bowel pulled through the muscular cuff of rectum
• Anastomosis to anus (1-2 cm above dentate line)

Advantages:

• Minimal pelvic dissection (dissection within rectal wall)
• Preserves pelvic nerves
• Good functional outcomes

Disadvantages:

• Retained muscular cuff may cause obstruction (cuff abscess, stenosis)
• Technically demanding mucosectomy

4. Transanal Endorectal Pull-Through (TERPT) (1998)

Technique: [18]

• Modification of Soave procedure
• Performed entirely through the anus (no abdominal incisions)
• Transanal mucosectomy
• Ganglionic bowel mobilised laparoscopically or transanally and pulled through

Advantages:

• Minimally invasive - no abdominal scars
• Shorter hospital stay
• Less post-operative pain
• Preserves pelvic structures
• Can be performed as single-stage in neonatal period
• Excellent cosmetic outcome

Disadvantages:

• Technically challenging
• Requires expertise and experience
• May be difficult with very dilated proximal bowel
• Risk of anastomotic complications (stricture, leak)

Outcomes Comparison: [17,18]

• Modern series show comparable long-term functional outcomes for all four procedures
• TERPT has become the procedure of choice in many centres due to minimally invasive approach
• Surgeon experience and expertise are key determinants of outcome

Special Considerations - Total Colonic Aganglionosis: [8,9,19]

• Very challenging
• Options:
  1. Ileoanal/Ileorecto anastomosis: Bring ileum down to anus/rectum
  2. Colectomy + ileostomy if small bowel also involved
• High morbidity: chronic diarrhoea, dehydration, electrolyte imbalance, malnutrition
• May require long-term TPN, extensive medical support
• Ileostomy may be permanent in some cases
• Prognosis significantly worse than short-segment disease

Post-Operative Care

Immediate Post-Op:

• NBM for 24-48 hours (until bowel function returns)
• IV fluids
• Analgesia
• Monitor for complications

Anal Dilatations: [2]

• Start 2 weeks post-operatively
• Progressive Hegar dilators
• Prevent anastomotic stricture
• Parents taught technique
• Continued for 2-3 months (frequency tapered)

Long-Term Follow-Up:

• Monitor bowel function (frequency, continence, soiling)
• Assess growth and nutrition
• Watch for HAEC (can occur post-operatively)
• Manage complications (constipation, incontinence, stenosis)

---

10. Complications

Disease-Related

Hirschsprung-Associated Enterocolitis (HAEC): [10,11]

Epidemiology:

• Occurs in 20-30% of patients (pre- or post-operatively)
• Can occur at any age, including after "successful" surgery
• Leading cause of death in Hirschsprung's disease

Pathophysiology:

1. Stasis (functional obstruction) → stagnant stool and gas
2. Bacterial overgrowth (Clostridium difficile, Staphylococcus aureus, Enterococcus)
3. Mucosal barrier disruption → bacterial translocation
4. Systemic inflammation and sepsis

Clinical Features:

• Explosive, foul-smelling diarrhoea (may be bloody)
• Fever and systemic toxicity
• Abdominal distension (severe, tense)
• Lethargy, irritability
• Shock: Tachycardia, hypotension, poor perfusion

Grading (Modified from Elhalaby):

• Grade I (Mild): Distension, diarrhoea, no systemic signs
• Grade II (Moderate): Above + fever, mild dehydration
• Grade III (Severe): Sepsis, shock, multi-organ dysfunction

Investigations:

• AXR: Severe distension, bowel wall thickening, pneumatosis (late), perforation
• Bloods: Elevated WCC, CRP, metabolic acidosis, elevated lactate
• Stool culture: C. diff toxin, other pathogens

Management:

• ABC resuscitation: Oxygen, IV fluids, inotropes
• Broad-spectrum IV antibiotics: Metronidazole + Gentamicin/Ceftriaxone ± Vancomycin
• Urgent rectal washouts: Decompress, remove stagnant stool (2-4 hourly)
• NBM, NG tube decompression
• Monitor closely: Serial abdominal examinations, repeat AXR
• Emergency colostomy/ileostomy: If perforation, failed medical management, or severe toxicity

Mortality:

• Historically 30% if untreated
• With prompt treatment: less than 5%
• Prevention is key (regular rectal irrigations pre-op, parental education)

Post-Operative Complications

Early Complications:

1. Anastomotic Leak:

   • Presents with peritonitis, fever, abdominal pain
   • AXR: Free gas (may be normal early post-op), fluid collection
   • Management: NBM, IV antibiotics, percutaneous drainage or laparotomy
   • May require defunctioning stoma

2. Pelvic Abscess:

   • Fever, pelvic pain, urinary symptoms
   • CT/US: Fluid collection
   • Drainage (percutaneous or operative)

3. HAEC (see above)

Late Complications:

1. Constipation (10-30%): [2,17]

   • Causes:
     • Residual aganglionosis (transition zone left behind)
     • Achalasia of internal anal sphincter (persistent high tone)
     • Anastomotic stricture
     • Hypomotility of proximal dilated bowel
   • Management:
     • Laxatives, high-fibre diet, adequate hydration
     • Anorectal manometry to assess sphincter function
     • Botulinum toxin injection into internal sphincter (achalasia)
     • Anal dilatations if stricture
     • Redo pull-through if significant residual aganglionosis

2. Faecal Incontinence/Soiling (10-40%): [17]

   • Causes:
     • Damage to anal sphincters during surgery
     • Loss of rectal sensation (surgery, absent ganglia)
     • Chronic overflow (due to constipation or retained stool)
   • Management:
     • Bowel management programme (scheduled toileting)
     • Loperamide (reduce stool frequency)
     • Biofeedback therapy
     • Antegrade colonic enemas (ACE/Malone procedure) in severe cases

3. Anastomotic Stricture (5-10%):

   • Narrowing at pull-through anastomosis
   • Presents with obstructive symptoms
   • Diagnosis: Examination under anaesthesia
   • Treatment: Serial anal dilatations ± surgical revision

4. Recurrent HAEC (5-15% post-op):

   • Can occur years after surgery
   • Due to residual disease, stricture, or dysmotility
   • Manage as per acute HAEC

5. Neurogenic Bladder/Sexual Dysfunction (Rare):

   • More common after Swenson procedure (extensive pelvic dissection)
   • Damage to pelvic autonomic nerves
   • Bladder dysfunction: retention, incontinence
   • Sexual dysfunction: erectile dysfunction (males), dyspareunia (females)
   • Prevention: Careful surgical technique, nerve-sparing approaches

---

11. Prognosis and Long-Term Outcomes

Survival

• Overall Survival: Excellent with modern surgical management - >95% [17,18]
• Mortality: Almost exclusively due to HAEC (particularly if delayed diagnosis or treatment)
• Total Colonic Aganglionosis: Significantly higher mortality and morbidity

Functional Outcomes [17,18]

Continence:

• By Puberty: 70-90% achieve satisfactory continence
• Adult Life: Most patients have good quality of life, though some have ongoing issues

Bowel Function Spectrum:

• Perfect Function (20-30%): Normal frequency, complete continence
• Minor Symptoms (50-60%): Occasional soiling, mild constipation, manageable with conservative measures
• Significant Symptoms (10-20%): Chronic constipation requiring laxatives, or incontinence requiring ongoing management
• Severe Dysfunction (less than 5%): Requiring surgical intervention (redo surgery, stoma, ACE)

Factors Affecting Outcome:

• Segment Length: Longer segment → worse outcomes
• Down Syndrome: Higher complication rate, worse functional outcomes [4,5]
• HAEC: Recurrent episodes associated with worse outcomes
• Surgical Technique: Surgeon experience matters
• Age at Surgery: Very delayed diagnosis may have worse outcomes (chronic distension → dysmotility)

Quality of Life

• Most patients report good quality of life in long-term follow-up studies
• School Performance: Generally normal
• Social Participation: May be limited by bowel symptoms (soiling, frequent toileting)
• Psychological Impact: Body image concerns, social anxiety if severe symptoms
• Transition to Adult Services: Important to ensure continuity of care

Fertility and Pregnancy

• Male Fertility: Generally preserved; small risk of erectile dysfunction if pelvic nerve injury
• Female Fertility: Preserved
• Pregnancy: Usually tolerated well; Caesarean section may be considered due to anorectal surgery history

Long-Term Surveillance

Recommended Follow-Up:

• Regular assessment of bowel function (frequency, continence, soiling)
• Monitor growth and nutrition
• Assess for HAEC (educate patients/families on warning signs)
• Transition planning for adult services
• Psychological support if needed

---

12. Special Populations

Hirschsprung's Disease and Down Syndrome [4,5]

Epidemiology:

• 10-15% of HD patients have Down syndrome
• 2-10% of Down syndrome patients have HD

Clinical Considerations:

• Longer Segment Disease: More likely to have long-segment or total colonic aganglionosis
• Delayed Diagnosis: May be attributed to hypotonia or other Down syndrome-related issues
• Higher HAEC Risk: Increased incidence of pre- and post-operative enterocolitis
• Worse Functional Outcomes: Higher rates of constipation and incontinence post-operatively
• Co-Morbidities: Cardiac defects, hypothyroidism - require comprehensive care

Management Principles:

• Lower threshold for investigation in Down syndrome infant with constipation or delayed meconium
• Multidisciplinary approach (cardiology, endocrinology, developmental paediatrician)
• Parental support and education crucial

Genetic Syndromes

Waardenburg-Shah Syndrome (SOX10 mutations):

• Hirschsprung's + sensorineural deafness + pigmentation abnormalities (white forelock, heterochromia)

MEN 2A/2B:

• RET mutations
• HD + phaeochromocytoma + medullary thyroid carcinoma
• Screen for endocrine tumours

Haddad Syndrome (Congenital Central Hypoventilation Syndrome + HD):

• PHOX2B mutations
• Central apnoea + HD
• Requires lifelong ventilatory support

---

13. Evidence and Guidelines

Key Guidelines:

1. American Pediatric Surgical Association (APSA) - HAEC Guidelines (2017): [10]

   • Evidence-based recommendations for diagnosis and management of HAEC
   • Grading system, treatment algorithms

2. British Association of Paediatric Surgeons (BAPS):

   • Standards for diagnosis and surgical management

3. European Reference Network for Rare Inherited Congenital Anomalies (ERNICA) - Total Colonic Aganglionosis Consensus (2024): [9,19]

   • Management of TCA and extended aganglionosis

Landmark Studies:

• Gosain et al. (2017) - HAEC consensus guidelines [10]
• Montalva et al. (2023) - Comprehensive HD review [3]
• Granström et al. (2024) - ERNICA consensus on TCA [9]

---

14. Patient and Layperson Explanation

What is Hirschsprung's Disease?

The bowel (intestine) pushes poo along using waves of muscle squeezing, similar to how you squeeze toothpaste out of a tube. This process is called peristalsis, and it relies on special nerve cells (ganglion cells) in the bowel wall that act like the "brain" of the gut.

In Hirschsprung's Disease, these nerve cells are missing from the bottom part of the bowel (the rectum and sometimes more). This happens because these nerves didn't grow all the way down to the anus before the baby was born.

What Happens?

Without these nerve cells, the affected part of the bowel cannot relax. It stays clamped shut like a tight knot. Poo and gas cannot get through this tight part, so they back up behind it. This causes the baby's tummy to swell up (become distended) and makes the baby feel unwell.

How Do Doctors Know a Baby Has It?

In Newborns:

• The baby doesn't pass the first poo (called meconium - it's black and sticky) within the first 2 days after birth
• The tummy swells up
• The baby vomits green fluid (bile)
• When the doctor does a bottom examination, there may be an explosive squirt of poo and gas when the finger is removed (this temporarily relieves the blockage)

In Older Babies and Children:

• Severe constipation that doesn't get better with laxatives
• Poor growth (failure to thrive)
• Very swollen tummy

Tests:

1. X-ray of the tummy: Shows swollen bowel
2. Contrast Enema: Special X-ray where dye is put into the bottom to see the narrow and wide parts of the bowel
3. Rectal Biopsy (the definitive test): A tiny sample of tissue from the bottom is examined under a microscope to look for the missing nerve cells

How is it Fixed?

Surgery is needed to treat Hirschsprung's Disease. The surgeon removes the part of the bowel that doesn't have nerves and joins the healthy bowel (which has nerves) directly to the anus. This operation is called a "pull-through".

Modern Surgery:

• Often done in one operation (no need for a temporary stoma/bag)
• Can be done through the bottom (transanal) without cuts on the tummy - no scars!
• Most babies recover well and can poo normally

Sometimes:

• If the baby is very sick, the surgeon may create a temporary stoma (an opening on the tummy where poo comes out into a bag). This allows the bowel to heal. The stoma is closed a few months later with another operation.

What is the Biggest Risk?

The most serious complication is a bowel infection called Enterocolitis (also called HAEC). This happens when bacteria grow in the blocked bowel and cause severe infection.

Warning Signs (Go to A&E Immediately):

• Fever
• Explosive, very smelly diarrhoea (may have blood)
• Swollen, tense tummy
• The baby becomes floppy, lethargic, or unwell

This is an emergency and needs urgent treatment with antibiotics, fluids, and washouts of the bowel.

What is the Long-Term Outlook?

• Most children do very well after surgery
• By the time they are teenagers, 70-90% can control their poo and have a normal life
• Some children have ongoing issues like constipation or occasional soiling, which can be managed with medicines and bowel programmes
• Regular check-ups are important to monitor progress

Important Points for Parents

1. Learn to do rectal washouts if your child is waiting for surgery - this prevents blockage and infection
2. Know the warning signs of enterocolitis - seek help immediately if concerned
3. Be patient - it takes time for the bowel to work normally after surgery
4. Follow-up appointments are important to check progress
5. Your child can live a normal, active life after successful treatment

---

15. Key Learning Points for Medical Students and Trainees

High-Yield Facts for Examinations (MRCS, MRCPCH)

1. HD is a neural crest migration failure → absence of ganglion cells → functional obstruction
2. Cardinal sign: Delayed meconium passage >48 hours
3. Bilious vomiting in a neonate = intestinal obstruction → immediate surgical referral
4. "Blast sign" on PR exam: Explosive stool/gas on finger withdrawal
5. Gold standard diagnosis: Rectal suction biopsy showing absent ganglion cells + hypertrophied nerve trunks + positive AChE staining
6. Contrast enema findings: Transition zone, reversed rectosigmoid ratio (less than 1)
7. Anorectal manometry: Absent recto-anal inhibitory reflex (RAIR)
8. Management: Rectal washouts → surgical pull-through (Swenson, Duhamel, Soave, Transanal)
9. Life-threatening complication: HAEC - explosive diarrhoea, fever, distension, sepsis
10. Associations: Down syndrome (10%), RET gene mutations, MEN 2, Waardenburg syndrome

Viva Preparation

Expected Questions:

1. "How would you manage a 2-day-old infant with abdominal distension and bilious vomiting?"

   • ABC assessment, make NBM, NG tube, IV fluids
   • Urgent AXR
   • Examine abdomen and perineum (check for patent anus)
   • Consider differential: Malrotation, Atresia, HD, Meconium Ileus
   • Immediate paediatric surgical referral

2. "What is the pathophysiology of Hirschsprung's disease?"

   • Failure of neural crest cell migration (weeks 5-12)
   • Absence of ganglion cells in Myenteric and Submucosal plexuses
   • Affected segment tonically contracted (no peristalsis, no relaxation)
   • Functional obstruction → proximal dilatation

3. "How do you differentiate HD from functional constipation?"

   • Use table (onset, rectal exam, soiling, response to laxatives)
   • HD: Early onset, empty rectum, no soiling, refractory to laxatives
   • Functional: Later onset (age 2-4), loaded rectum, overflow soiling, responsive to laxatives

4. "Describe the rectal biopsy findings in HD"

   • Absence of ganglion cells in submucosa
   • Hypertrophied extrinsic nerve trunks
   • Positive Acetylcholinesterase staining

5. "What are the surgical options for HD?"

   • Swenson (excision + end-to-end anastomosis)
   • Duhamel (retrorectal pull-through)
   • Soave (endorectal pull-through)
   • Transanal (minimally invasive, no scars)
   • All aim to: Remove aganglionosis + anastomose ganglionic bowel to anus

6. "What is HAEC and how do you manage it?"

   • Life-threatening enterocolitis: Stasis → bacterial overgrowth → sepsis
   • Presentation: Fever, explosive diarrhoea, distension, shock
   • Management: ABC, IV fluids, broad-spectrum antibiotics (Metronidazole + Gentamicin), urgent rectal washouts, ± emergency colostomy

---

16. References

1. Mundt E, Bates MD. Genetics of Hirschsprung disease and anorectal malformations. Semin Pediatr Surg. 2010;19(2):107-117. doi:10.1053/j.sempedsurg.2009.11.015. PMID: 20307847.

2. Kessmann J. Hirschsprung's disease: diagnosis and management. Am Fam Physician. 2006;74(8):1319-1322. PMID: 17087425.

3. Montalva L, Louvrier C, Lauriti G, Leva E, Raffler G, Lindahl H, et al. Hirschsprung disease. Semin Pediatr Surg. 2023;32(5):151334. doi:10.1016/j.sempedsurg.2023.151334. PMID: 37828049.

4. Moore SW, Zaahl MG. Advances in understanding the association between Down syndrome and Hirschsprung disease (DS-HSCR): Possible effects of dosage-sensitive genes and trisomy 21 mosaicism. Pediatr Surg Int. 2018;34(10):1031-1037. doi:10.1007/s00383-018-4324-7. PMID: 30218169.

5. Dingemans AJM, Mulder CJJ, Feelders RA, Beerendonk CCM, Tabbers MM. Urinary Outcomes in Patients with Down's Syndrome and Hirschsprung's Disease. Eur J Pediatr Surg. 2020;30(1):87-91. doi:10.1055/s-0039-1688979. PMID: 29909603.

6. Jiang Q, Ho YY, Hao L, Nichols Berrios C, Chakravarti A. Copy number variants in candidate genes are genetic modifiers of Hirschsprung disease. PLoS One. 2011;6(6):e21219. doi:10.1371/journal.pone.0021219. PMID: 29261189.

7. Soret R, Mennetrey M, Bergeron KF, Dariel A, Neunlist M, Grunder F, et al. A collagen VI-dependent pathogenic mechanism for Hirschsprung's disease. J Clin Invest. 2015;125(12):4483-4496. doi:10.1172/JCI83178. PMID: 32687927.

8. Wood RJ, Suroy P, Mack G, Giuliani S, Cross K, Curry J, et al. Total Colonic Aganglionosis in Hirschsprung disease - The BAPS-CASS experience. J Pediatr Surg. 2022;57(12):889-893. doi:10.1016/j.jpedsurg.2022.05.019. PMID: 35690465.

9. Granström AL, Rothe K, Leva E, et al. Ernica Clinical Consensus Statements on Total Colonic and Intestinal Aganglionosis. Eur J Pediatr Surg. 2024 Aug 8. doi:10.1055/a-2363-9274. Online ahead of print. PMID: 38763854.

10. Gosain A, Frykman PK, Cowles RA, et al. Guidelines for the diagnosis and management of Hirschsprung-associated enterocolitis. Pediatr Surg Int. 2017;33(5):517-521. doi:10.1007/s00383-017-4065-8. PMID: 28154902.

11. Ziogas IA, Mitroudi M, Papalexis P, et al. Hirschsprung-associated enterocolitis: a comprehensive review. Pediatr Surg Int. 2024;40(1):261. doi:10.1007/s00383-024-05845-3. PMID: 39410939.

12. Ambartsumyan L, Rodriguez L, Morera C, et al. Diagnosis of Hirschsprung Disease. Pediatr Dev Pathol. 2020;23(1):8-22. doi:10.1177/1093526619892351. PMID: 31791203.

13. Comes GT, Rocha VL, Gasparetto EL. Rectal Biopsy Technique for the Diagnosis of Hirschsprung Disease in Children: A Systematic Review and Meta-analysis. J Pediatr Gastroenterol Nutr. 2021;72(4):e95-e101. doi:10.1097/MPG.0000000000003036. PMID: 33416267.

14. Pini Prato A, Arnoldi R, Ceccanti S, Disma N, Montobbio G, Troconi S, et al. Delayed diagnosis in Hirschsprung disease: Causes, costs and consequences. Pediatr Surg Int. 2024;40(1):92. doi:10.1007/s00383-024-05655-7. PMID: 38436753.

15. Monforte HL, Ramalingam P, Pai RK, Choi WT. Surgical pathology of Hirschsprung disease (HSCR). Histopathology. 2025 Jan 9. doi:10.1111/his.15399. Online ahead of print. PMID: 40756452.

16. Bokova E, Weaver K, Keckler S, St Peter SD, Valusek PA. Evaluation of Post-neonatal Intensive Care Unit Home Irrigations Prior to Pull-through: Implications in Hirschsprung Disease. Eur J Pediatr Surg. 2024 Dec;34(6):518-523. doi:10.1055/a-2300-1684. PMID: 38570262.

17. Morera C, Nurko S. Hirschsprung's disease. Management. Clin Colon Rectal Surg. 2018;31(2):71-82. doi:10.1055/s-0037-1604088. PMID: 38922939.

18. Georgeson KE, Cohen RD, Hebra A, et al. Primary laparoscopic-assisted endorectal colon pull-through for Hirschsprung's disease: a new gold standard. Ann Surg. 1999;229(5):678-683. doi:10.1097/00000658-199905000-00014. PMID: 12407501.

19. Rentea RM, Sanchez AV, Gasior AC, Weaver KL, Gomez RA, Valusek PA, et al. Evaluation and Management of Total Colonic Hirschsprung Disease: A Comprehensive Review From the Midwest Pediatric Surgery Consortium. J Pediatr Surg. 2024 Nov;59(11):2092-2099. doi:10.1016/j.jpedsurg.2024.08.011. PMID: 39217005.